Pharma Mar, S.A.
PHMMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $58 | $22 | $60 | $63 |
| Short-Term Investments | $114 | $106 | $81 | $91 |
| Receivables | $49 | $60 | $37 | $35 |
| Inventory | $62 | $50 | $51 | $51 |
| Other Curr. Assets | $0 | $8 | $7 | $7 |
| Total Curr. Assets | $285 | $249 | $236 | $250 |
| Property Plant & Equip (Net) | $67 | $58 | $58 | $59 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $2 | $1 | -$79 | -$89 |
| Tax Assets | $46 | $38 | $36 | $36 |
| Other NC Assets | $0 | $1 | $81 | $92 |
| Total NC Assets | $116 | $99 | $97 | $99 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $401 | $348 | $333 | $350 |
| Liabilities | – | – | – | – |
| Payables | $51 | $37 | $42 | $39 |
| Short-Term Debt | $15 | $11 | $10 | $8 |
| Tax Payable | $0 | $0 | $0 | $2 |
| Deferred Revenue | $6 | $0 | $0 | $0 |
| Other Curr. Liab. | $29 | $29 | $26 | $31 |
| Total Curr. Liab. | $104 | $88 | $79 | $83 |
| LT Debt | $43 | $38 | $39 | $40 |
| Deferred Rev, NC | $15 | $20 | $16 | $17 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $60 | $59 | $57 | $59 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $3 | $3 | $3 |
| Total Liabilities | $164 | $147 | $136 | $141 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $11 | $11 | $11 |
| Retained Earnings | $203 | $188 | $165 | $168 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $232 | $202 | $197 | $208 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $401 | $348 | $333 | $350 |
| Net Debt | -$1 | $27 | -$12 | -$15 |